CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
receiving lower radiation doses, in patients with locally advanced pancreatic cancer, without increasing the rate of serious gastro...
Philadelphia, Pennsylvania, United States and 12 other locations
is to assess the efficacy and safety of Acoustic Cluster Therapy (ACT) when given in addition to chemotherapy for treatment of Locally Advanced Pancreatic...
Phase 2
Philadelphia, Pennsylvania, United States and 9 other locations
Initial study to evaluate local control and the preferred method of attachment of the CivaSheet in the setting of suspected close or positive margins...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States of America and 5 other locations
combination with VCN-01 in patients with unresectable or metastatic pancreatic adenocarcinoma and serous epithelial ovarian cancer....
Phase 1
Philadelphia, Pennsylvania, United States
This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread...
Phase 2
Philadelphia, Pennsylvania, United States and 108 other locations
in combination with gemcitabine and nab-paclitaxel in patients with Pancreatic Ductal Adenocarcinoma (PDAC) who have been previously untreat...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 11 other locations
This is a Phase 1a, open label, single dose, extended study of safety and biokinetics of RAD301 in healthy human volunteers and individuals with PDAC...
Phase 1
Princeton, New Jersey, United States and 1 other location
This is a nonrandomized, uncontrolled, open-label, multicenter Phase 2 study to evaluate the efficacy, safety, and tolerability of futibatinib in com...
Phase 2
Mickleton, New Jersey, United States and 21 other locations
of the drugs niraparib and ipilimumab, on the patients and their pancreatic cancer. This study will involve two different treatment...
Phase 2
Philadelphia, Pennsylvania, United States and 1 other location
The purpose of this study is to evaluate the safety and efficacy of atebimetinib in combination with modified GnP compared with SOC GnP alone.
Phase 3
Philadelphia, Pennsylvania, United States and 47 other locations
Clinical trials
Research sites
Resources
Legal